Does semaglutide cause memory loss or cognitive side effects?

Is memory loss listed as a side effect of semaglutide in the UK?

No. The NHS patient information for semaglutide and the UK Summary of Product Characteristics do not list memory loss, confusion or cognitive impairment among the known side effects. The side effects that are recognised, and which clinical trials consistently identified, are centred on the digestive system: nausea, vomiting, diarrhoea, constipation, indigestion and reduced appetite. Headache, dizziness and fatigue also appear on the list, and those last two are worth noting because fatigue in particular can make concentration feel harder without directly affecting memory.

A question our prescribers hear most weeks is whether 'brain fog' during treatment means something is wrong. It is a fair question, and the honest answer is that feeling mentally slower than usual is not the same as a pharmacological effect on memory. The distinction matters. You can read the full recognised side-effect profile on the NHS semaglutide medicines page, which is kept current by clinical editors and is the most reliable first reference for UK patients.

The large STEP 1 trial, which enrolled over 1,900 adults and ran for 68 weeks, did not flag cognitive adverse events as a finding of note. That does not mean no individual ever experiences concentration difficulties, but it does mean those experiences are not appearing at a frequency that stands out against placebo in controlled conditions.

Could something else explain the brain fog people describe?

Almost certainly, in most cases. Semaglutide works partly by reducing appetite significantly, and people on semaglutide for weight loss often eat considerably less than they did before, sometimes without fully replacing lost nutrients. When total calorie intake drops sharply, or when protein and carbohydrate intake falls below what the brain needs to function well, concentration and short-term recall can suffer. This is not unique to GLP-1 medicines; it is a well-documented effect of significant calorie restriction in general.

Dehydration is another common factor. Nausea and vomiting, even mild, reduce fluid intake, and many people on semaglutide do not compensate adequately. The brain is sensitive to even modest dehydration: reaction time slows, working memory takes a hit, and tasks that usually feel automatic require more effort. Correcting hydration often resolves the fogginess within a day or two.

Disrupted sleep is worth mentioning too. Gastrointestinal discomfort is most common in the first few weeks of treatment or after a dose increase, and broken sleep compounds cognitive fatigue considerably. If your Wegovy dose has recently changed and you are sleeping poorly because of GI symptoms, that combination is a more likely explanation for memory-like difficulties than a direct drug effect on the brain.

What does science say about GLP-1 receptors in the brain?

This is genuinely interesting territory, and it is also genuinely unsettled. GLP-1 receptors are found not only in the pancreas and gut but throughout the central nervous system, including areas associated with memory and learning such as the hippocampus. That anatomical fact has prompted researchers to investigate whether semaglutide and related medicines might have effects on cognition, and some early signals are positive rather than negative: animal studies and small human trials have explored whether GLP-1 receptor agonists could be protective against neurodegeneration. Some researchers are investigating possible roles in Alzheimer's disease.

None of that is settled enough to be clinical fact yet, and it is mentioned here only because it shapes the honest answer to this page's question. The picture that is emerging from early research is not one of semaglutide damaging cognition; it is, if anything, pointing the other way. But the evidence base for human cognitive outcomes remains thin, and responsible content acknowledges that. For a fuller look at what semaglutide does in the body, the semaglutide overview covers the mechanism in plain language. The NICE appraisal of semaglutide for weight management (TA875) sets out the evidence base that underpins its licensed use in the UK, and cognitive harm was not among the risks that gave the committee pause.

What should you do if you notice memory or concentration changes on semaglutide?

Tell your prescriber. That is the clearest, most practical answer. Cognitive changes are not the kind of symptom to monitor quietly and hope they pass, partly because the causes are worth sorting out either way. If the issue is nutritional, your prescriber or a dietitian can help you eat better within your reduced appetite. If it is dehydration, that is straightforward to fix. If it is sleep disruption from GI side effects, there are management strategies that can help without needing to abandon treatment.

If you are experiencing any side effect that concerns you, the MHRA's Yellow Card scheme exists precisely for this: patients and healthcare professionals can report suspected side effects there, and those reports contribute to the ongoing post-market monitoring of all medicines including semaglutide. Reporting is not an accusation against the medicine; it is how the system learns. You can also explore how Wegovy may affect memory and concentration for more on this specific angle, or look at the evidence on whether Wegovy causes memory loss directly.

For those weighing up all aspects of treatment before starting, including what side effects are and are not supported by evidence, our prescribers are the right people to speak to. Treatment cost is sometimes a consideration at that stage too; the Wegovy price page sets out what private treatment typically involves. When you are ready, speak to our prescribers through a free consultation — they review every case the same day, personally.